John McCoy
President chez CARDIOVASCULAR SYSTEMS, INC.
Fortune : 2 M $ au 30/04/2024
Postes actifs de John McCoy
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CARDIOVASCULAR SYSTEMS, INC. | President | - | - |
| Treasurer | - | - | |
| ABBOTT LABORATORIES | Comptroller/Controller/Auditor | 01/09/2023 | - |
| Corporate Officer/Principal | 01/01/2018 | 01/01/2021 | |
| Treasurer | 01/01/2021 | 01/09/2023 |
Historique de carrière de John McCoy
Anciens postes connus de John McCoy
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| BAXALTA INC | Comptroller/Controller/Auditor | 01/06/2015 | 01/01/2016 |
Statistiques
Internationale
| Etats-Unis | 4 |
Opérationnelle
| Comptroller/Controller/Auditor | 2 |
| Treasurer | 2 |
| President | 1 |
Sectorielle
| Health Technology | 4 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| Entreprise privées | 2 |
|---|---|
Baxalta, Inc.
 Baxalta, Inc. BiotechnologyHealth Technology Baxalta, Inc. engages in the research, development, and manufacture of biopharmaceutical products. Its portfolio includes treatments for hemophilia, bleeding disorders, immune deficiencies, alpha-1 antitrypsin deficiency, burns, and shock. The company was founded on March 13, 2015 and is headquartered in Chicago, IL. | Health Technology |
Cardiovascular Systems, Inc.
 Cardiovascular Systems, Inc. Medical SpecialtiesHealth Technology Cardiovascular Systems, Inc. is a medical device company, which engages in the development and commercialization of solutions for treating vascular and coronary disease. It offers orbital atherectomy systems for both peripheral and coronary commercial applications. The company was founded in 1989 and is headquartered in St. Paul, MN. | Health Technology |
- Bourse
- Insiders
- John McCoy
- Expérience
